Notably, mucinous adenocarcinoma with intrapulmonary metastasis harboring concurrent KRAS and GNAS mutations was identified in a 14-year-old boy with type 1 CPAM [23], suggesting that GNAS mutations may play a critical role in tumor progression and metastasis. Here, KRAS is linked to neoplasm.